CSL - Current Liabilities

Stock Price
145.00
Daily Change
-2.38 -1.61%
Monthly
-20.73%
Yearly
-44.76%
Q1 Forecast
150.05

CSL reported $4.82B in Current Liabilities for its fiscal semester ending in June of 2025.





Current Liabilities Change Date
Alterity Therapeutics Limited AUD 4.38M 849.82K Jun/2023
Arca Biopharma USD 20.97M 8.86M Sep/2025
aTyr Pharma USD 15.68M 148K Sep/2025
Bio Path USD 7.86M 3.12M Jun/2025
Brainstorm Cell Therapeutics USD 9.02M 495K Sep/2025
Cara Therapeutics USD 10.68M 9.48M Jun/2025
CSL USD 4.82B 1.26B Jun/2025
Curis USD 19.37M 745K Jun/2025
Esperion Therapeutics USD 359.03M 60.24M Sep/2025
Immunic USD 30.08M 2.77M Sep/2025
Infinity Pharmaceuticals USD 12.06M 775K Jun/2023
Minerva Neurosciences USD 2.67M 143K Sep/2025
Sangamo BioSciences USD 47.66M 1.9M Jun/2025
TherapeuticsMD USD 5.82M 655K Jun/2024